10 June 2014 - Deborah Wilkes
Archived
The business environment in the first quarter of 2014 proved difficult for many branded OTC players, according to the new OTC Results Comparisons Briefing just published by OTCToolbox. Several companies – including Bayer, GlaxoSmithKline, Johnson & Johnson, Merck KGaA, Novartis and Pfizer – highlighted the lower incidence of colds and flu compared with the first quarter of 2013.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.